Home
Neuropharmagen
Neuropharmagen® is a breakthrough in pharmacogenetics that helps to identify the safest and most appropriate psychotropic medication for each patient, by analyzing their DNA. It provides the most extensive genetic-based information on drug efficacy, metabolism and adverse effects.
Neuropharmagen® helps reduce the time spent searching for the most effective treatment choices unique to each patient. This allows for a faster stabilization of patients and better quality of life..
How does it work?
Neuropharmagen® testing is carried out on a saliva sample:
- DNA markers of efficacy, optimal dosage and adverse effects are analyzed.
- A series of specific recommendations are provided based on the test results, to help the physician choose the most appropriate choices for each patient.
DR. MIGUEL VEGA
Psychiatrist at Ramon y Cajal Hospital, Madrid
The intention to change treatment after a detailed analysis of the results, happened in 57% the patients studied. We also identified many patients in our sample who had at least a better treatment choice within the same therapeutic group: 81% were receiving suboptimal treatment, or had at least a probably better treatment option.
Identifying these parameters and knowing that there may be a better alternative at the beginning of a long treatment of a psychiatric patient makes this genetic marker test a therapeutic tool too good to ignore it.
Vega M. Psiquiatria.com. 2012; 16:5.
Identifying these parameters and knowing that there may be a better alternative at the beginning of a long treatment of a psychiatric patient makes this genetic marker test a therapeutic tool too good to ignore it.
Vega M. Psiquiatria.com. 2012; 16:5.

Doctors´opinions
DR. MIGUEL VEGA
Psychiatrist at Ramon y Cajal Hospital, Madrid
Deciding treatment changes in 57% of our study sample not based on a trial-and-error approach or serendipity ,but on objective supporting data from this test gives great peace of mind to the psychiatrist in his daily practice.
More info
GAD / aged 50
GAD is a 50 year-old woman who has resistant depression and responds poorly to treatment, with poor metabolism of the various drugs that she has tried up to now.
Her psychiatrist recommended her to take the Neuropharmagen test and the results led to improved treatment by identifying the most suitable drugs for her particular genetic profile: in this case, dosages of Citalopram and Topiramate were adjusted.
Her psychiatrist recommended her to take the Neuropharmagen test and the results led to improved treatment by identifying the most suitable drugs for her particular genetic profile: in this case, dosages of Citalopram and Topiramate were adjusted.

True success stories
GAD / aged 50
GAD is a 50 year-old woman who has resistant depression and responds poorly to treatment, with poor metabolism of the various drugs that she has tried up to now.
Her psychiatrist recommended her to take the Neuropharmagen test and the results led to improved treatment by identifying the most suitable drugs for her particular genetic profile: in this case, dosages of Citalopram and Topiramate were adjusted.
GAD is a 50 year-old woman who has resistant depression and responds poorly to treatment, with poor metabolism of the various drugs that she has tried up to now.
Her psychiatrist recommended her to take the Neuropharmagen test and the results led to improved treatment by identifying the most suitable drugs for her particular genetic profile: in this case, dosages of Citalopram and Topiramate were adjusted.
More info
Contact us

(+34) 972 183 211
Where to find us
NEUROPHARMAGEN IS AN AB-BIOTICS PRODUCT - Copyright (c) 2009 / 2018 - All Rights Reserved / Legal Notice / Privacy Policy / Credits